Cannabis - Aspectos regulatorios: políticas y regulación

Políticas de cannabis: Generalidades

• Fuente: PubMed [Internet]. Bethesda (MD): US National Library of Medicine National Institutes of Health; [consulta 25 mayo 2022]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/
• Detalles de búsqueda: ("Cannabis policy"[All Fields]) AND (y_5[Filter])

 

2022

• Philbin MM, Giovenco DP, Mauro PM. Commentary on Weinberger et al.: Tobacco and cannabis policies as drivers of nicotine and cannabis co-use - research and measurement implications to move the field forward. Addiction. junio de 2022;117(6):1778-80.
• Goodman S, Wadsworth E, Hammond D. Reasons for Purchasing Cannabis From Illegal Sources in Legal Markets: Findings Among Cannabis Consumers in Canada and U.S. States, 2019-2020. J Stud Alcohol Drugs. mayo de 2022;83(3):392-401.
• Goodman S, Hammond D. Perceptions of the health risks of cannabis: estimates from national surveys in Canada and the United States, 2018-2019. Health Educ Res. 24 de marzo de 2022;37(2):61-78.
• Pacula RL, Smart R, Lira MC, Pessar SC, Blanchette JG, Naimi TS. Relationships of Cannabis Policy Liberalization With Alcohol Use and Co-Use With Cannabis: A Narrative Review. Alcohol Res. 2022;42(1):06.
• Kitchen C, Kabba JA, Fang Y. Status and Impacts of Recreational and Medicinal Cannabis Policies in Africa: A Systematic Review and Thematic Analysis of Published and «Gray» Literature. Cannabis Cannabinoid Res. 5 de enero de 2022;
• Gabri AC, Galanti MR, Orsini N, Magnusson C. Changes in cannabis policy and prevalence of recreational cannabis use among adolescents and young adults in Europe-An interrupted time-series analysis. PLoS One. 2022;17(1):e0261885.

2021

• Schauer GL. Cannabis Policy in the United States: Implications for Public Health. J Natl Cancer Inst Monogr. 28 de noviembre de 2021;2021(58):39-52.
• Crépault J-F, Rehm J, Room R. Legalization as more effective control? Parallels between the end of alcohol prohibition (1927) and the legalization of cannabis (2018) in Ontario, Canada. Int J Drug Policy. noviembre de 2021;97:103367.
• Calvert CM, Erickson D. Recreational cannabis legalization and alcohol purchasing: a difference-in-differences analysis. J Cannabis Res. 7 de julio de 2021;3(1):27.
• Monaghan M, Wincup E, Hamilton I. Scandalous decisions: explaining shifts in UK medicinal cannabis policy. Addiction. julio de 2021;116(7):1925-33.
• Benedetti E, Resce G, Brunori P, Molinaro S. Cannabis Policy Changes and Adolescent Cannabis Use: Evidence from Europe. Int J Environ Res Public Health. 13 de mayo de 2021;18(10):5174.
• Ryan JE, McCabe SE, Boyd CJ. Medicinal Cannabis: Policy, Patients, and Providers. Policy Polit Nurs Pract. mayo de 2021;22(2):126-33.
• Obradovic I. From prohibition to regulation: A comparative analysis of the emergence and related outcomes of new legal cannabis policy models (Colorado, Washington State and Uruguay). Int J Drug Policy. mayo de 2021;91:102590.
• Johnson JK, Doonan SM. Cannabis Policy Heterogeneity and Effects on Research-Complexity Expected. JAMA Netw Open. 1 de marzo de 2021;4(3):e212545.
• Fischer B, Hall W. New Zealand’s failed cannabis legalization referendum - implications for cannabis policy reform. Lancet Reg Health West Pac. febrero de 2021;7:100080.
• Kim JH, Weinberger AH, Zhu J, Barrington-Trimis J, Wyka K, Goodwin RD. Impact of state-level cannabis legalization on poly use of alcohol and cannabis in the United States, 2004-2017. Drug Alcohol Depend. 1 de enero de 2021;218:108364.
• Fataar F, Goodman S, Wadsworth E, Hammond D. Consumer perceptions of «legal» and «illegal» cannabis in US states with legal cannabis sales. Addict Behav. enero de 2021;112:106563.
• López-Pelayo H, Matrai S, Balcells-Olivero M, Campeny E, Braddick F, Bossong MG, et al. Supporting Future Cannabis Policy - Developing a Standard Joint Unit: A Brief Back-Casting Exercise. Front Psychiatry. 2021;12:675033.

2020

• Areesantichai C, Perngparn U, Pilley C. Current cannabis-related situation in the Asia-Pacific region. Curr Opin Psychiatry. julio de 2020;33(4):352-9.
• Trangenstein PJ. Social Bots Likely Pose an Undue Influence to Cannabis Policy. Am J Public Health. marzo de 2020;110(3):264-5.

2019

• Rehm J, Elton-Marshall T, Sornpaisarn B, Manthey J. Medical marijuana. What can we learn from the experiences in Canada, Germany and Thailand? Int J Drug Policy. diciembre de 2019;74:47-51.
• Bowling C, Glantz SA. Civic Engagement in California Cannabis Policy Development. J Psychoactive Drugs. diciembre de 2019;51(5):391-9.
• Chow RM, Marascalchi B, Abrams WB, Peiris NA, Odonkor CA, Cohen SP. Driving Under the Influence of Cannabis: A Framework for Future Policy. Anesth Analg. junio de 2019;128(6):1300-8.
• Stevens A. Is policy «liberalization» associated with higher odds of adolescent cannabis use? A re-analysis of data from 38 countries. Int J Drug Policy. abril de 2019;66:94-9.
• Smart R, Pacula RL. Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: Findings from state policy evaluations. Am J Drug Alcohol Abuse. 2019;45(6):644-63.
• Shover CL, Humphreys K. Six policy lessons relevant to cannabis legalization. Am J Drug Alcohol Abuse. 2019;45(6):698-706.
• Arora K, Qualls SH, Bobitt J, Lum HD, Milavetz G, Croker J, et al. Measuring Attitudes Toward Medical and Recreational Cannabis Among Older Adults in Colorado. Gerontologist. 14 de mayo de 2019;
• Belackova V, Roubalova Stefunkova M, van de Ven K. Overview of «home» cultivation policies and the case for community-based cannabis supply. Int J Drug Policy. 11 de junio de 2019;71:36-46.
• Bowling C, Glantz SA. Civic Engagement in California Cannabis Policy Development. J Psychoactive Drugs. 12 de junio de 2019;
• Chow RM, Marascalchi B, Abrams WB, Peiris NA, Odonkor CA, Cohen SP. Driving Under the Influence of Cannabis: A Framework for Future Policy. Anesth Analg. junio de 2019;128(6):1300-8.
• Gonzalez M, Sanders-Jackson A, Henriksen L. Social Capital and Tobacco Retail Outlet Density: An Empirical Test of the Relationship. Am J Health Promot. septiembre de 2019;33(7):1020-7.
• Goodman S, Leos-Toro C, Hammond D. Methods to Assess Cannabis Consumption in Population Surveys: Results of Cognitive Interviewing. Qual Health Res. agosto de 2019;29(10):1474-82.
• Goodman S, Leos-Toro C, Hammond D. Methods to Assess Cannabis Consumption in Population Surveys: Results of Cognitive Interviewing. Qual Health Res. 2 de enero de 2019;1049732318820523 .
• Haines-Saah RJ, Mitchell S, Slemon A, Jenkins EK. «Parents are the best prevention»? Troubling assumptions in cannabis policy and prevention discourses in the context of legalization in Canada. Int J Drug Policy. junio de 2019;68:132-8.
• Kotlaja MM, Carson JV. Cannabis Prevalence and National Drug Policy in 27 Countries: An Analysis of Adolescent Substance Use. Int J Offender Ther Comp Criminol. mayo de 2019;63(7):1082-99 .
• Melchior M, Nakamura A, Bolze C, Hausfater F, El Khoury F, Mary-Krause M, et al. Does liberalisation of cannabis policy influence levels of use in adolescents and young adults? A systematic review and meta-analysis. BMJ Open. 10 de julio de 2019;9(7):e025880.
• Resko S, Ellis J, Early TJ, Szechy KA, Rodriguez B, Agius E. Understanding Public Attitudes Toward Cannabis Legalization: Qualitative Findings From a Statewide Survey. Subst Use Misuse. 19 de abril de 2019;1-13 .
• Shover CL, Humphreys K. Six policy lessons relevant to cannabis legalization. Am J Drug Alcohol Abuse. 14 de marzo de 2019;1-9 .
• Stevens A. Is policy «liberalization» associated with higher odds of adolescent cannabis use? A re-analysis of data from 38 countries. Int J Drug Policy. abril de 2019;66:94-9 .

2018

• Belackova V, Wilkins C. Consumer agency in cannabis supply - Exploring auto-regulatory documents of the cannabis social clubs in Spain. Int J Drug Policy. 2018;54:26-34 .
• Blevins CE, Marsh E, Banes KE, Stephens RS, Walker DD, Roffman RA. The Implications of Cannabis Policy Changes in Washington on Adolescent Perception of Risk, Norms, Attitudes, and Substance Use. Subst Abuse. 2018;12:1178221818815491 .
• Chow RM, Marascalchi B, Abrams WB, Peiris NA, Odonkor CA, Cohen SP. Driving Under the Influence of Cannabis: A Framework for Future Policy. Anesth Analg. 20 de junio de 2018 .
• Haines-Saah RJ, Mitchell S, Slemon A, Jenkins EK. «Parents are the best prevention»? Troubling assumptions in cannabis policy and prevention discourses in the context of legalization in Canada. Int J Drug Policy. 17 de julio de 2018 .
• Hall W, West R, Marsden J, Humphreys K, Neale JO, Petry N. The need for more consistent evidential standards in cannabis policy evaluations. Addiction. agosto de 2018;113(8):1553-4 .
• Hughes B, Wiessing L, Des Jarlais D, Griffiths P. Could cannabis liberalisation lead to wider changes in drug policies and outcomes? Int J Drug Policy. 2018;51:156-9 .
• Hughes CE. The trajectories of cannabis and tobacco policies in the United States, Uruguay, Canada and Portugal: is more cross-substance learning possible outside the United States? Addiction. abril de 2018;113(4):603-5 .
• Neu P. [Discussing possible new regulations in german cannabis policy with special regard to the experiences in the Netherlands and Colorado]. Fortschr Neurol Psychiatr. 2018;86(7):428-33 .
• Pardal M. An analysis of Belgian Cannabis Social Clubs’ supply practices: A shapeshifting model? Int J Drug Policy. 2018;57:32-41 .
• Rogeberg O. Prohibition, regulation or laissez faire: The policy trade-offs of cannabis policy. Int J Drug Policy. 2018;56:153-61 .
• Rolles S. The different outcomes of legislative- versus advocacy-led development of cannabis policy. Addiction. abril de 2018;113(4):606-7 .
• Skliamis K, Korf DJ. An Exploratory Study of Cannabis Festivals and Their Attendees in Two European Cities: Amsterdam and Berlin. J Psychoactive Drugs. junio de 2018;50(2):105-13 .
• Zarhin D, Negev M, Vulfsons S, Sznitman SR. Rhetorical and regulatory boundary-work: The case of medical cannabis policy-making in Israel. Soc Sci Med. noviembre de 2018;217:1-9 .

2017

• Adam C, Raschzok A. Cannabis policy and the uptake of treatment for cannabis-related problems. Drug Alcohol Rev. 2017;36(2):171-7 .
• Alshaarawy O, Anthony JC. The replicability of cannabis use prevalence estimates in the United States. Int J Methods Psychiatr Res. 2017;26(2) .
• Budney AJ, Borodovsky JT. The potential impact of cannabis legalization on the development of cannabis use disorders. Prev Med. noviembre de 2017;104:31-6 .
• Cambron C, Guttmannova K, Fleming CB. State and National Contexts in Evaluating Cannabis Laws: A Case Study of Washington State. J Drug Issues. enero de 2017;47(1):74-90 .
• Červený J, Chomynová P, Mravčík V, van Ours JC. Cannabis decriminalization and the age of onset of cannabis use. Int J Drug Policy. 2017;43:122-9 .
• Chatwin C. UNGASS 2016: Insights from Europe on the development of global cannabis policy and the need for reform of the global drug policy regime. Int J Drug Policy. 2017;49:80-5 .
• Decorte T, Pardal M, Queirolo R, Boidi MF, Sánchez Avilés C, Parés Franquero Ò. Regulating Cannabis Social Clubs: A comparative analysis of legal and self-regulatory practices in Spain, Belgium and Uruguay. Int J Drug Policy. 2017;43:44-56 .
• Gourdet C, Giombi KC, Kosa K, Wiley J, Cates S. How four U.S. states are regulating recreational marijuana edibles. Int J Drug Policy. 2017;43:83-90 .
• Grbic J, Goddard P, Ryder D. Observations of the role of science in the United States medical cannabis state policies: Lessons learnt. Int J Drug Policy. 2017;42:109-14 .
• Klitzner MD, Thomas S, Schuler J, Hilton M, Mosher J. The New Cannabis Policy Taxonomy on APIS: Making Sense of the Cannabis Policy Universe. J Prim Prev. junio de 2017;38(3):295-314 .
• Lancaster K, Seear K, Ritter A. Making medicine; producing pleasure: A critical examination of medicinal cannabis policy and law in Victoria, Australia. Int J Drug Policy. 2017;49:117-25 .
• Mendiburo-Seguel A, Vargas S, Oyanedel JC, Torres F, Vergara E, Hough M. Attitudes towards drug policies in Latin America: Results from a Latin-American Survey. Int J Drug Policy. 2017;41:8-13 .
• Stevens A, Pacula RL. Advancing knowledge on cannabis policy using evidence from North America. Int J Drug Policy. 2017;42:36-8 .
• Weiss SRB, Howlett KD, Baler RD. Building smart cannabis policy from the science up. Int J Drug Policy. 2017;42:39-49 .

2016

• Sznitman SR, Taubman DS. Drug Use Normalization: A Systematic and Critical Mixed-Methods Review. J Stud Alcohol Drugs. 2016;77(5):700-9 .
• Kirst M, Kolar K, Chaiton M, Schwartz R, Emerson B, Hyshka E, et al. A common public health-oriented policy framework for cannabis, alcohol and tobacco in Canada? Can J Public Health. 16 de marzo de 2016;106(8):e474-476 .
• Kalant H. A critique of cannabis legalization proposals in Canada. Int J Drug Policy. 2016;34:5-10 .
• Fischer B, Rehm J, Crépault J-F. Realistically furthering the goals of public health by cannabis legalization with strict regulation: Response to Kalant. Int J Drug Policy. agosto de 2016;34:11-6 .
• Dirisu O, Shickle D, Elsey H. Influence of legal status on the uptake of cannabis in young people. Curr Opin Psychiatry. 2016;29(4):231-5 .
• Crépault J-F, Rehm J, Fischer B. The Cannabis Policy Framework by the Centre for Addiction and Mental Health: A proposal for a public health approach to cannabis policy in Canada. Int J Drug Policy. 2016;34:1-4 .
• Bretteville-Jensen AL. Expected lessons from the US experience with alternative cannabis policy regimes. Addiction. 2016;111(12):2090-1 .
• Alvarez A, Gamella JF, Parra I. Cannabis cultivation in Spain: A profile of plantations, growers and production systems. Int J Drug Policy. 2016;37:70-81 .
• Stein DJ. Position statement on cannabis. S Afr Med J. 16 de 2016;106(6):45-6 .

2015

• Belackova V, Maalsté N, Zabransky T, Grund JP. «Should I Buy or Should I Grow?» How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic. Int J Drug Policy. marzo de 2015;26(3):296-310 .
• Decorte T. Cannabis social clubs in Belgium: organizational strengths and weaknesses, and threats to the model. Int J Drug Policy. febrero de 2015;26(2):122-30 .
• Fergusson DM, Boden JM, Horwood LJ. Psychosocial sequelae of cannabis use and implications for policy: findings from the Christchurch Health and Development Study. Soc Psychiatry Psychiatr Epidemiol. septiembre de 2015;50(9):1317-26 .
• Hall W. Getting to grips with the cannabis problem: the evolving contributions and impact of Griffith Edwards. Addiction. julio de 2015;110 Suppl 2:36-9 .
• Ogrodnik M, Kopp P, Bongaerts X, Tecco JM. An economic analysis of different cannabis decriminalization scenarios. Psychiatr Danub. septiembre de 2015;27 Suppl 1:S309-314 .
• Ramo DE, Popova L, Grana R, Zhao S, Chavez K. Cannabis Mobile Apps: A Content Analysis. JMIR Mhealth Uhealth. 12 de agosto de 2015;3(3):e81 .
• Sachs J, McGlade E, Yurgelun-Todd D. Safety and Toxicology of Cannabinoids. Neurotherapeutics. octubre de 2015;12(4):735-46 .
• Sznitman SR, Bretteville-Jensen AL. Public opinion and medical cannabis policies: examining the role of underlying beliefs and national medical cannabis policies. Harm Reduct J. 14 de octubre de 2015;12:46 .
• Sznitman SR, Lewis N. Is cannabis an illicit drug or a medicine? A quantitative framing analysis of Israeli newspaper coverage. Int J Drug Policy. mayo de 2015;26(5):446-52 .

2014

• Hall W. Robin Room and cannabis policy: dangerous comparisons. Drug Alcohol Rev. noviembre de 2014;33(6):612-6.
• Kilmer B. Policy designs for cannabis legalization: starting with the eight Ps. Am J Drug Alcohol Abuse. julio de 2014;40(4):259-61 .
• Månsson J. A dawning demand for a new cannabis policy: A study of Swedish online drug discussions. Int J Drug Policy. julio de 2014;25(4):673-81 .
• Pardo B. Cannabis policy reforms in the Americas: a comparative analysis of Colorado, Washington, and Uruguay. Int J Drug Policy. julio de 2014;25(4):727-35.
• Shanahan M, Gerard K, Ritter A. Preferences for policy options for cannabis in an Australian general population: A discrete choice experiment. Int J Drug Policy. julio de 2014;25(4):682-90 .
• Williams J, Bretteville-Jensen AL. Does liberalizing cannabis laws increase cannabis use? J Health Econ. julio de 2014;36:20-32 .